Combination Therapy with a CD4-CDR3 Peptide Analog and Cyclosporin A to Prevent Graft-vs-Host Disease in a MHC-Haploidentical Bone Marrow Transplantation Model

Author： Townsend R.M.   Gilbert M.J.   Korngold R.  

Publisher： Academic Press

ISSN： 1521-6616

Source： Clinical Immunology, Vol.86, Iss.1, 1998-01, pp. : 115-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Xenogeneic humoral Graft-Vs-Host disease following Hamster-to-Rat bone marrow transplantation

By Miki T.   Lee Y.-H.   Tandin A.   Subbotin V.   Kuddus R.   Rao A.S.   Fung J.J.   Starzl T.E.   Valdivia L.A.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 1036-1037

Elsevier

Access to resources Recommend Favorite

Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease

By Lee Y.-H.   Miki T.   Kuddus R.   Tandin A.   Goller A.L.   Subbotin V.   Fung J.J.   Peach R.   Valdivia L.A.   Rao A.S.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 1032-1033

Elsevier

Access to resources Recommend Favorite

Specificity of Effector Mechanisms in Syngeneic Graft-vs-Host Disease: Recognition of the MHC Class II Invariant Chain Peptide (CLIP)

By Hess A.   Thoburn C.   Bright E.   Horwitz L.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 725-727

Elsevier

Access to resources Recommend Favorite

Injection of CD4 + and CD8 + cells with donor or host accessory cells induces acute graft-vs-host disease in human skin in immunodeficient mice

By Matsumoto M.   Katoh Y.   Nakamura Y.   Shimakura Y.   Hagihara M.   Yabe H.   Yabe M.   Inokuchi S.   Kato S.   Shimamura K.  

Experimental Hematology, Vol. 29, Iss. 6, 2001-06 ,pp. : 720-727

Elsevier

Access to resources Recommend Favorite

A New Bone Marrow Transplantation Method for the Prevention of Graft- Versus-Host Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 547-554

Bentham Science Publishers

Access to resources Recommend Favorite